Reardon Tighe - Insider Non-Derivative Transactions at Janux Therapeutics, Inc. (JANX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 3, 2024, Reardon Tighe's relationship to Janux Therapeutics, Inc. (JANX) is Officer (Acting Chief Financial Officer), and currently has 3,340,018 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other JANX insiders.
Data Source: SEC.
Reardon Tighe - Insider Non-Derivative Transactions of JANX Common Stock
Reardon Tighe - Insider Non-Derivative Transactions at JANX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 4, 2024 | Sell -- (Common Stock) | 131196 | 54.75 | 633673 |
| Jun 4, 2024 | Sell -- (Common Stock) | 691525 | 54.75 | 3340018 |
| Nov 14, 2023 | P -- (Common Stock) | 849854 | 5.87 | 849854 |